Time-dependent increases in ouabain-sensitive Na+, K+-ATPase activity in aortas from diabetic rats: The role of prostanoids and protein kinase C

Life Sciences

Volumn 87, Issue 9-10, 2010, Pages 302-308

  Gallo, Luana C ^a   Davel, Ana Paula C ^a,b   Xavier, Fabiano E ^c   Rossoni, Luciana V ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

COX 2; Diabetes; Ouabain sensitive Na+, K+ ATPase activity; Prostanoids; Protein kinase C

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CYCLOOXYGENASE 2; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NITRIC OXIDE SYNTHASE; OUABAIN; POTASSIUM CHLORIDE; PROSTANOID; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA II; RIDOGREL; THROMBOXANE A2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES; VASCULAR RING; VASOCONSTRICTION; VASODILATATION;

ANIMALS; AORTA, THORACIC; BLOTTING, WESTERN; CYCLOOXYGENASE 2; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; MALE; OUABAIN; PROSTAGLANDIN H2; PROSTAGLANDINS; PROTEIN KINASE C; RATS; RATS, WISTAR; SODIUM-POTASSIUM-EXCHANGING ATPASE; THROMBOXANE A2; TIME FACTORS; VASOCONSTRICTION; VASODILATION;

RATTUS; STROPHANTHUS GRATUS;

EID: 77955768328     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2010.07.005     Document Type: Article

References (48)

1. Abebe W., MacLeod K.M. Enhanced arterial contractility to noradrenaline in diabetic rats is associated with increased phosphoinositide metabolism. Canadian Journal of Physiology and Pharmacology 1991, 69:335-361.
2. Akamine E.H., Urakawa T.A., de Oliveira M.A., Nigro D., de Carvalho M.H., de Cássia A., Tostes R., Fortes Z.B. Decreased endothelium-dependent vasodilation in diabetic female rats: role of prostanoids. Journal of Vascular Research 2006, 43:401-410.
3. 2+ stores and cell responsiveness. The American Journal of Physiology 1993, 264:C1367-C1387.
4. Bojunga J., Dresar-Mayert B., Usadel K.H., Kusterer K., Zeuzem S. Antioxidative treatment reverses imbalances of nitric oxide synthase isoform expression and attenuates tissue-cGMP activation in diabetic rats. Biochemical and Biophysical Research Communications 2004, 316:771-780.
5. Brass L.F., Shaller C.C., Belmonte E.J. Inositol 1,4,5-triphosphate-induced granule secretion in platelets. Evidence that the activation of phospholipase C mediated by platelet thromboxane receptors involves a guanine nucleotide binding protein-dependent mechanism distinct from that of thrombin. The Journal of Clinical Investigation 1987, 79:1269-1275.
6. +-ATPase activity in acute and chronic diabetes and with aldose reductase inhibition. Diabetes 1988, 37:558-562.
7. Davel A.P.C., Rossoni L.V., Vassallo D.V. Effects of ouabain on the pressor response to phenylephrine and on the sodium pump activity in diabetic rats. European Journal of Pharmacology 2000, 406:419-427.
8. +ATPase activity in the tail artery from l-NAME-treated rats. Life Science 2003, 74(5):613-627.
9. Duran M.J., Pierre S.V., Carr D.L., Pressley T.A. The isoform-specific region of the Na, K-ATPase catalytic subunit: role in enzyme kinetics and regulation by protein kinase C. Biochemistry 2004, 43:16174-16183.
10. Durante W., Sem A.K., Sunahara F.A. Impairment of endothelium-dependent relaxation in aortae from spontaneously diabetic rats. British Journal of Pharmacology 1988, 94:463-468.
11. Geraldes P., King G.L. Activation of protein kinase C isoforms and its impact on diabetic complications. Circulation Research 2010, 106:1319-1331.
12. Guo M., Wu M.H., Korompai F., Yuan S.Y. Upregulation of PKC genes and isozymes in cardiovascular tissues during early stages of experimetal diabetes. Physiological Genomics 2003, 12:139-146.
13. Guo Z., Su W., Allen S., Pang H., Daugherty A., Smart E., Gong M.C. COX-2 up-regulation and vascular smooth muscle contractile hyperreactivity in spontaneous diabetic db/db mice. Cardiovascular Research 2005, 67(4):723-735.
14. + ATPase activity by a protein kinase C-mediated pathway in rabbit aorta. The American Journal of Physiology 1991, 261:H38-H45.
15. + ATPase activity in rabbit aorta by hiperglycemia. Possible role of endothelium-derived nitric oxide. The Journal of Clinical Investigation 1992, 90:727-732.
16. Hattori Y., Kawasaki H., Kanno M. Increased contractile responses to endothelin-1 and U46619 via a protein kinase C-mediated nifedipine-sensitive pathway in diabetic rat aorta. Research Communications in Molecular Pathology and Pharmacology 1999, 104(1):73-80.
17. Inoguchi T., Battan R., Handler E., Sportsman J.R., Heath W., King G.L. Preferential elevation of protein kinase C isoform βII and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:11059-11063.
18. Kakkar R., Mantha S.V., Kalra J., Prasad K. Time course study of oxidative stress in aorta and heart of diabetic rat. Clinical Science 1996, 91:441-448.
19. Lee T.S., Saltsman K.A., Ohashi H., King G.L. Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. Proceedings of the National Academy of Sciences of the United States of America 1989, 86(13):5141-5145.
20. +ATPase. Circulation Research 1980, 46:714-720.
21. +-ATPase by protein kinase C. Biochimica et Biophysica Acta 1990, 1052:143-151.
22. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. The Journal of Biological Chemistry 1951, 193:265-275.
23. Marin J., Redondo J. Vascular sodium pump: endothelial modulation and alterations in some pathological processes and aging. Pharmacology & Therapeutics 1999, 84:249-271.
24. McNally P.G., Watt P.A., Rimmer T., Burden A.C., Hearnshaw J.R., Thurston H. Impaired contraction and endothelium-dependent relaxation in isolated resistance vessels from patients with insulin-dependent diabetes mellitus. Clinical Science 1994, 87:31-36.
25. Michea L., Irribarra V., Goecke A., Marusic E.T. Reduced Na-K pump but increased Na-K-2Cl cotransporter in aorta of streptozotocin-induced diabetic rat. The American Journal of Physiology 2001, 280:851-858.
26. 2 attenuates inducible nitric oxide synthase-mediated cardiovascular abnormalities in streptozotocin-induced diabetic rats. Diabetes 2009, 58(10):2355-2364.
27. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. The FASEB Journal 1995, 9(7):484-496.
28. + ATPase in rat aorta. Diabetes 1991, 40(11):1560-1563.
29. Okon E.B., Chung A.W., Zhang H., Laher I., van Breemen C. Hyperglycemia and hyperlipidemia are associated with endothelial dysfunction during the development of type 2 diabetes. Canadian Journal of Physiology and Pharmacology 2007, 85(5):562-567.
30. + ATPase activity in the aorta may explain the unaltered contractile responses to KCl in diabetes mellitus. Indian Journal of Physiology and Pharmacology 1993, 37(3):199-203.
31. Pandoffi A., Grilli A., Cilli C., Patruno A., Giaccari A., di Silvestre S., Luttis M.A., Pellegrini G., Capani F., Consoli A., Felaco M. Phenotype modulation in cultures of vascular smooth muscle cells from diabetic rats: association with increased nitric oxide synthase expression and superoxide anion generation. Journal of Cellular Physiology 2003, 196(2):378-385.
32. Pedemonte C.H., Pressley T.A., Lokhandwala M.F., Cinelli A.R. Regulation of Na, K-ATPase transport activity by protein kinase C. The Journal of Membrane Biology 1997, 155:219-227.
33. Peredo H.A., Feleder E.C., Graschinsky E.A. Time-course of the alterations in prostanoid production and in contractile responses of mesenteric beds isolated from streptozotocin diabetic rats. Prostaglandins Leukotrienes and Essential Fatty Acids 1999, 60(4):269-274.
34. Pieper G.M. Enhanced, unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus: importance of disease duration. Diabetologia 1999, 42(2):204-213.
35. Ponte A., Marin J., Arribas S., Gonzáles R., Barrus M.T., Salaices M., Sanchez-Ferrer C.F. Endothelial modulation of ouabain-induced contraction and sodium pump activity in aortas of normotensive Wistar-Kyoto and spontaneously hypertensive rats. Journal of Vascular Research 1996, 33(2):164-174.
36. Quilley J., Chen Y.J. Role of COX-2 in the enhanced vasoconstrictor effect of arachidonic acid in the diabetic rat kidney. Hypertension 2003, 42(4):837-843.
37. +ATPase in ouabain-induced hypertension. British Journal of Pharmacology 2002, 135(3):771-781.
38. Rossoni L.V., dos Santos L., Barker L.A., Vassallo D.V. Ouabain changes arterial blood pressure and vascular reactivity to phenylephrine in l-NAME-induced hypertension. Journal of Cardiovascular Pharmacology 2003, 41(1):105-116.
39. Shi Y., Vanhoutte P.M. Oxidative stress and COX cause hyper-responsiveness in vascular smooth muscle of the femoral artery from diabetic rats. British Journal of Pharmacology 2008, 154(3):639-651.
40. + ATPase activity in rabbit aorta. Diabetologia 1993, 36:212-217.
41. +ATPase. Journal of Bioenergetics and Biomembranes 1992, 24(3):249-261.
42. +ATPase activity in vascular smooth muscle from streptozotocin diabetic rat. Cardiovascular Research 1997, 34(1):137-144.
43. + ATPase by insulin: why and how?. Molecular and Cellular Biochemistry 1998, 182(1-2):121-133.
44. 2. The American Journal of Physiology 1989, 257:H1327-H1333.
45. Tesfamariam B., Brown M.L., Cohen R.A. Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. The Journal of Clinical Investigation 1991, 87(5):1643-1648.
46. Tesfamariam B., Gupta S., Oates P.J., Ruderman N.B., Cohen R.A. Reduced Na+K+pump activity in diabetic rabbit carotid artery: reversal by aldose reductase inhibition. The American Journal of Physiology 1993, 256:H1189-H1194.
47. + ATPase activity in the vascular smooth muscle. Blood Vessels 1978, 15:198-207.
48. Xavier F.E., Davel A.P., Rossoni L.V., Vassallo D.V. Time-dependent hyperreactivity to phenylephrine in aorta from untreated diabetic rats: role of prostanoids and calcium mobilization. Vascular Pharmacology 2003, 40(1):67-76.